Please login to the form below

Not currently logged in
Email:
Password:

Quintiles joins forces with Archimedes to quantify healthcare decisions

Biopharmaceutical services company will use Archimedes' healthcare modeling technology

Quintiles has formed a partnership with a San Francisco-based healthcare modeling company to offer a new range of services aimed at reducing the time and expense of bring new therapies to market.

The biopharmaceutical services company will use Archimedes's technology to capture “predictive simulations from real-world research”, said global head of integrated clinical services Rick Sax.

“Turning data into insights will allow customers to make faster, better decisions across the product lifecycle and increase their probability of success,” he added.

Quintiles will promote and provide access to Archimedes' ARCHeS Innovator technology, which enables users to run clinically realistic virtual trials.

Mika Newton, vice president, ARCHeS and consulting business leader for Archimedes, said: “Biopharma companies are under enormous pressure to maximise the efficiency and strategic positioning of products they are developing and marketing.

“This partnership between Archimedes and Quintiles makes advanced simulation modeling and premier medical evidence accessible and fully integrated into customers' clinical research and commercial activities.”

Archimedes is a spin-off of the US managed care consortium Kaiser Permanente and has worked with the FDA, Novo Nordisk and Bristol-Myers Squibb.

2nd April 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics